Zimmer Biomet Holdings, Inc. (VIE:ZBH)

Market Cap	15.34B
Revenue (ttm)	6.83B
Net Income (ttm)	686.36M
Shares Out	n/a
EPS (ttm)	3.44
PE Ratio	22.35
Forward PE	10.68
Dividend	0.86 (1.11%)
Ex-Dividend Date	Sep 30, 2025

Volume	n/a
Average Volume	12
Open	77.82
Previous Close	77.52
Day's Range	76.96 - 78.00
52-Week Range	75.04 - 108.40
Beta	n/a
RSI	39.27
Earnings Date	Nov 5, 2025

About Zimmer Biomet Holdings

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open hear...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 1927
• Employees: 17,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: ZBH

Financial Performance

In 2024, Zimmer Biomet Holdings's revenue was $7.68 billion, an increase of 3.85% compared to the previous year's $7.39 billion. Earnings were $903.80 million, a decrease of -11.74%.

Financial numbers in USD